Search filters

List of works by Timon Bogumil

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

scientific article published on 2 September 2009

Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b

scientific article published on 01 December 2004

Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study

article

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

scientific article published on 13 May 2016

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis

scientific article published in October 2003

Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients

scientific article published on 01 June 2002

Interleukin 17F level and interferon β response in patients with multiple sclerosis

scientific article

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial

scientific article published on 27 September 2011

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

scientific article

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

scientific article published on June 2008

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

scientific article published on 15 June 2012

Paulina is supported by:

About Paulina

Help